#obesity #type2diabetes #rarediseases #cancer #oncology #womenshealth #NovoNordisk #EliLilly #Lilly #GSK #severeasthma #JnJ #biologics #Otsuka #IgAN #kidneydisease #Sanofi #MS #BeOneMedicines #CLL #SLL #BMS #CELMoD #multiplemyeloma #Pfizer #breastcancer #CorceptTherapeutics #SGRA
zurl.co/xauLJ
zurl.co/xauLJ
11 high-impact drugs to look out for in 2026
Medicines for obesity, diabetes, rare diseases, cancer, and women's health feature among Clarivate's annual round-up of 11 Drugs to Watch this year.
pharmaphorum.com
January 27, 2026 at 9:37 AM
BeOne Medicines Price Target Cut to $411: Truist cut BeOne Medicines' price target to $411 from $412 on Apr 9, 2026 — a $1 (0.24%) change reported by Yahoo Finance that likely reflects a model update, not a… 👈 Read full analysis #BeOneMedicines #StockMarket #PriceTarget #Truist #InvestmentNews
BeOne Medicines Price Target Cut to $411
Truist cut BeOne Medicines' price target to $411 from $412 on Apr 9, 2026 — a $1 (0.24%) change reported by Yahoo Finance that likely reflects a model update, not a material shift.
dlvr.it
April 9, 2026 at 12:54 PM
BeOne Medicines Price Target Cut to $411: Truist cut BeOne Medicines' price target to $411 from $412 on Apr 9, 2026 — a $1 (0.24%) change reported by Yahoo Finance that likely reflects a model update, not a… 👈 Read full analysis #BeOneMedicines #StockMarket #PriceTarget #Truist #InvestmentNews
#WorldCLLDay stories like Kabite's remind us of what #AccessToTreatment can mean for individuals and families around the world. 🌍✨
Learn more about how access to treatment for CLL is helping people regain their health and hope: buff.ly/OUqFLBG
#PatientStories #TheMaxFoundation #BeOneMedicines
Learn more about how access to treatment for CLL is helping people regain their health and hope: buff.ly/OUqFLBG
#PatientStories #TheMaxFoundation #BeOneMedicines
The Max Foundation Renews Partnership to Expand Access to Chronic Lymphocytic Leukemia Treatment
We renewed our collaboration with BeOne Medicines to help expand access to treatment for people living with chronic lymphocytic leukemia.
buff.ly
September 1, 2026 at 5:21 PM
#WorldCLLDay stories like Kabite's remind us of what #AccessToTreatment can mean for individuals and families around the world. 🌍✨
Learn more about how access to treatment for CLL is helping people regain their health and hope: buff.ly/OUqFLBG
#PatientStories #TheMaxFoundation #BeOneMedicines
Learn more about how access to treatment for CLL is helping people regain their health and hope: buff.ly/OUqFLBG
#PatientStories #TheMaxFoundation #BeOneMedicines
#oncology #BeOneMedicines #UKinnovationpassport #HCCtherapy #hepatocellularcarcinoma #livercancer #investigationalantibody #InnovationPassport #bispecificantibody #BGBB2033 #InnovativeLicensingandAccessPathway #MHRA #patientaccess #ILAP #investigationalmedicine #ILAPPartners
zurl.co/aWAU6
zurl.co/aWAU6
BeOne Medicines secures UK innovation passport for HCC therapy - PharmaTimes
Designation supports accelerated access for investigational antibody
pharmatimes.com
August 10, 2026 at 9:01 AM
BeOne Medicines Downgraded After Analyst Review: Downgrade reported Apr 2, 2026; ONC shares moved intraday after the rating change. Institutional focus should be on milestones and cash runway. 👈 Read full analysis #BeOneMedicines #StockMarket #FinancialNews #InvestmentInsights #Downgrade
BeOne Medicines Downgraded After Analyst Review
Downgrade reported Apr 2, 2026; ONC shares moved intraday after the rating change. Institutional focus should be on milestones and cash runway.
dlvr.it
April 5, 2026 at 9:27 AM
BeOne Medicines Downgraded After Analyst Review: Downgrade reported Apr 2, 2026; ONC shares moved intraday after the rating change. Institutional focus should be on milestones and cash runway. 👈 Read full analysis #BeOneMedicines #StockMarket #FinancialNews #InvestmentInsights #Downgrade
Patients with newly diagnosed #mantlecell #lymphoma (MCL) could avoid chemotherapy with a #regimen based on #BeOneMedicines' #Brukinsa and #rituximab.
pharmaphorum.com/news/brukins...
pharmaphorum.com/news/brukins...
Brukinsa data raise chemo-free hope for mantle cell lymphoma
Patients with newly diagnosed mantle cell lymphoma could avoid chemotherapy with a regimen based on BeOne's Brukinsa, according to the MANGROVE trial.
pharmaphorum.com
June 30, 2026 at 12:52 PM
Patients with newly diagnosed #mantlecell #lymphoma (MCL) could avoid chemotherapy with a #regimen based on #BeOneMedicines' #Brukinsa and #rituximab.
pharmaphorum.com/news/brukins...
pharmaphorum.com/news/brukins...
#BeOneMedicines' Beqalzi has been cleared for a form of #lymphoma by the #FDA, and the US regulator has also granted a second approval to #TaihoOncology's Inqovi in #leukaemia.
pharmaphorum.com/news/fda-han...
pharmaphorum.com/news/fda-han...
May 14, 2026 at 12:25 PM
#BeOneMedicines' Beqalzi has been cleared for a form of #lymphoma by the #FDA, and the US regulator has also granted a second approval to #TaihoOncology's Inqovi in #leukaemia.
pharmaphorum.com/news/fda-han...
pharmaphorum.com/news/fda-han...
Ich möchte ja so gerne wissen, was für ein sensationelles Angebot die Stadt #Basel #BeOneMedicines für ihren Hauptsitz gemacht hat, dass es vorteilhafter ist als auf den #CaymanIsland. Frage für die SP und für die @woz.ch?
May 28, 2025 at 5:16 PM
Ich möchte ja so gerne wissen, was für ein sensationelles Angebot die Stadt #Basel #BeOneMedicines für ihren Hauptsitz gemacht hat, dass es vorteilhafter ist als auf den #CaymanIsland. Frage für die SP und für die @woz.ch?
*BTK inhibitors and B-cell malignancies: a guide for pharmacists*
This article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
This article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists
Bruton tyrosine kinase (BTK) is a protein that plays an important role in the signalling, proliferation, migration and survival of B-cells. For this reason, medicines that target BTK — known as BTK…
buff.ly
May 18, 2026 at 6:00 PM
*BTK inhibitors and B-cell malignancies: a guide for pharmacists*
This article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
This article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
*How can pharmacists best support patients with chronic lymphocytic leukaemia?*
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
How can pharmacists best support patients with chronic lymphocytic leukaemia?
Over the past decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this…
buff.ly
December 19, 2025 at 6:30 PM
*How can pharmacists best support patients with chronic lymphocytic leukaemia?*
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
*Supporting pharmacists in improving the care delivered for people with cancer*
#ThePJ's cancer ‘hub page’ includes educational resources on blood cancer as part of continued partnership with #BeOneMedicines
#ThePJ's cancer ‘hub page’ includes educational resources on blood cancer as part of continued partnership with #BeOneMedicines
Supporting pharmacists in improving the care delivered for people with cancer
Pharmacists are playing an increasingly important role in supporting people with cancer, working within multidisciplinary teams and improving outcomes. Around 3.5 million people are currently living…
buff.ly
December 15, 2025 at 7:30 PM
*Supporting pharmacists in improving the care delivered for people with cancer*
#ThePJ's cancer ‘hub page’ includes educational resources on blood cancer as part of continued partnership with #BeOneMedicines
#ThePJ's cancer ‘hub page’ includes educational resources on blood cancer as part of continued partnership with #BeOneMedicines
*How can pharmacists best support patients with chronic lymphocytic leukaemia?*
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
How can pharmacists best support patients with chronic lymphocytic leukaemia?
Over the past decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this…
buff.ly
December 14, 2025 at 11:01 AM
*How can pharmacists best support patients with chronic lymphocytic leukaemia?*
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
*Management of Waldenstrom’s macroglobulinaemia*
An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options
Supported by #BeOneMedicines
An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options
Supported by #BeOneMedicines
Management of Waldenstrom's macroglobulinaemia
Introduction Waldenstrom’s macroglobulinaemia (WM) is a rare type of non-hodgkin lymphoma, characterised by the presence of a monoclonal IgM protein[1,2]. Approximately 350 people are diagnosed…
buff.ly
December 13, 2025 at 11:00 AM
*Management of Waldenstrom’s macroglobulinaemia*
An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options
Supported by #BeOneMedicines
An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options
Supported by #BeOneMedicines
*Chronic lymphocytic leukaemia: diagnosis and management*
An overview of how to diagnose, manage and monitor patients with CLL, emphasising the important role of pharmacists
Supported by #BeOneMedicines
An overview of how to diagnose, manage and monitor patients with CLL, emphasising the important role of pharmacists
Supported by #BeOneMedicines
Chronic lymphocytic leukaemia: diagnosis and management
Introduction Chronic lymphocytic leukaemia (CLL) is a form of blood cancer affecting the lymphocytes. The term ‘chronic’ derives from the fact that this type of leukaemia is slow growing, compared to…
buff.ly
December 12, 2025 at 6:31 PM
*Chronic lymphocytic leukaemia: diagnosis and management*
An overview of how to diagnose, manage and monitor patients with CLL, emphasising the important role of pharmacists
Supported by #BeOneMedicines
An overview of how to diagnose, manage and monitor patients with CLL, emphasising the important role of pharmacists
Supported by #BeOneMedicines
*BTK inhibitors and B-cell malignancies: a guide for pharmacists*
This article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
This article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists
Bruton tyrosine kinase (BTK) is a protein that plays an important role in the signalling, proliferation, migration and survival of B-cells. For this reason, medicines that target BTK — known as BTK…
buff.ly
December 11, 2025 at 7:02 PM
*BTK inhibitors and B-cell malignancies: a guide for pharmacists*
This article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
This article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
*Supporting pharmacists in improving the care delivered for people with cancer*
#ThePJ's cancer ‘hub page’ includes educational resources on blood cancer as part of continued partnership with #BeOneMedicines
#ThePJ's cancer ‘hub page’ includes educational resources on blood cancer as part of continued partnership with #BeOneMedicines
Supporting pharmacists in improving the care delivered for people with cancer
Pharmacists are playing an increasingly important role in supporting people with cancer, working within multidisciplinary teams and improving outcomes. Around 3.5 million people are currently living…
buff.ly
December 10, 2025 at 7:30 PM
*Supporting pharmacists in improving the care delivered for people with cancer*
#ThePJ's cancer ‘hub page’ includes educational resources on blood cancer as part of continued partnership with #BeOneMedicines
#ThePJ's cancer ‘hub page’ includes educational resources on blood cancer as part of continued partnership with #BeOneMedicines
*How can pharmacists best support patients with chronic lymphocytic leukaemia?*
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
How can pharmacists best support patients with chronic lymphocytic leukaemia?
Over the past decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this…
buff.ly
December 9, 2025 at 7:30 PM
*How can pharmacists best support patients with chronic lymphocytic leukaemia?*
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
As therapies for #CLL have evolved, so has pharmacists’ role in treating people with this type of blood cancer
Supported by #BeOneMedicines
*Management of Waldenstrom’s macroglobulinaemia*
An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options
Supported by #BeOneMedicines
An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options
Supported by #BeOneMedicines
Management of Waldenstrom's macroglobulinaemia
Introduction Waldenstrom’s macroglobulinaemia (WM) is a rare type of non-hodgkin lymphoma, characterised by the presence of a monoclonal IgM protein[1,2]. Approximately 350 people are diagnosed…
buff.ly
December 8, 2025 at 7:30 PM
*Management of Waldenstrom’s macroglobulinaemia*
An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options
Supported by #BeOneMedicines
An overview of the symptoms and diagnosis of Waldenstrom’s macroglobulinaemia, as well as treatment options
Supported by #BeOneMedicines
*Chronic lymphocytic leukaemia: diagnosis and management*
An overview of how to diagnose, manage and monitor patients with CLL, emphasising the important role of pharmacists
Supported by #BeOneMedicines
An overview of how to diagnose, manage and monitor patients with CLL, emphasising the important role of pharmacists
Supported by #BeOneMedicines
Chronic lymphocytic leukaemia: diagnosis and management
Introduction Chronic lymphocytic leukaemia (CLL) is a form of blood cancer affecting the lymphocytes. The term ‘chronic’ derives from the fact that this type of leukaemia is slow growing, compared to…
buff.ly
December 7, 2025 at 11:00 AM
*Chronic lymphocytic leukaemia: diagnosis and management*
An overview of how to diagnose, manage and monitor patients with CLL, emphasising the important role of pharmacists
Supported by #BeOneMedicines
An overview of how to diagnose, manage and monitor patients with CLL, emphasising the important role of pharmacists
Supported by #BeOneMedicines
*Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists*
This learning article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
This learning article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists
Bruton tyrosine kinase (BTK) is a protein that plays an important role in the signalling, proliferation, migration and survival of B-cells. For this reason, medicines that target BTK — known as BTK…
buff.ly
December 6, 2025 at 11:01 AM
*Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists*
This learning article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
This learning article provides an overview of the available BTK inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice. Supported by #BeOneMedicines
This interactive learning article, supported by #BeOneMedicines, provides an overview of the available #BTKIs for the treatment of B-cell malignancies to support pharmacists with their use in practice
#cancercare #cancertreatment #pharmacy
#cancercare #cancertreatment #pharmacy
Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists
Bruton tyrosine kinase (BTK) is a protein that plays an important role in the signalling, proliferation, migration and survival of B-cells. For this reason, medicines that target BTK — known as BTK…
buff.ly
October 17, 2025 at 5:30 PM
This interactive learning article, supported by #BeOneMedicines, provides an overview of the available #BTKIs for the treatment of B-cell malignancies to support pharmacists with their use in practice
#cancercare #cancertreatment #pharmacy
#cancercare #cancertreatment #pharmacy
This interactive learning article, supported by #BeOneMedicines, provides an overview of the available #BTKIs for the treatment of B-cell malignancies to support pharmacists with their use in practice
#cancercare #cancertreatment #pharmacy
#cancercare #cancertreatment #pharmacy
Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists
Bruton tyrosine kinase (BTK) is a protein that plays an important role in the signalling, proliferation, migration and survival of B-cells. For this reason, medicines that target BTK — known as BTK…
buff.ly
October 9, 2025 at 5:30 PM
This interactive learning article, supported by #BeOneMedicines, provides an overview of the available #BTKIs for the treatment of B-cell malignancies to support pharmacists with their use in practice
#cancercare #cancertreatment #pharmacy
#cancercare #cancertreatment #pharmacy
This interactive learning article, supported by #BeOneMedicines, provides an overview of the available Bruton tyrosine kinase inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice
#BTKIs #cancercare #cancertreatment #pharmacy
#BTKIs #cancercare #cancertreatment #pharmacy
Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists
Bruton tyrosine kinase (BTK) is a protein that plays an important role in the signalling, proliferation, migration and survival of B-cells. For this reason, medicines that target BTK — known as BTK…
buff.ly
October 6, 2025 at 5:30 PM
This interactive learning article, supported by #BeOneMedicines, provides an overview of the available Bruton tyrosine kinase inhibitors for the treatment of B-cell malignancies to support pharmacists with their use in practice
#BTKIs #cancercare #cancertreatment #pharmacy
#BTKIs #cancercare #cancertreatment #pharmacy
This new collection of cancer content, brought to you in partnership with BeOne Medicines, provides access to educational resources that support professional development for improved patient
#cancercare #BeOneMedicines #cancermedication
#cancercare #BeOneMedicines #cancermedication
Cancer
As the number of patients being diagnosed and living with cancer continues to grow, pharmacists are playing an increasingly important role in supporting patients, working within multidisciplinary…
buff.ly
July 31, 2025 at 6:03 PM
This new collection of cancer content, brought to you in partnership with BeOne Medicines, provides access to educational resources that support professional development for improved patient
#cancercare #BeOneMedicines #cancermedication
#cancercare #BeOneMedicines #cancermedication